BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23539503)

  • 1. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
    Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
    Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
    Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle.
    Dyer EC; Jacques AM; Hoskins AC; Ward DG; Gallon CE; Messer AE; Kaski JP; Burch M; Kentish JC; Marston SB
    Circ Heart Fail; 2009 Sep; 2(5):456-64. PubMed ID: 19808376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin I.
    Vikhorev PG; Song W; Wilkinson R; Copeland O; Messer AE; Ferenczi MA; Marston SB
    Biophys J; 2014 Nov; 107(10):2369-80. PubMed ID: 25418306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate.
    Papadaki M; Vikhorev PG; Marston SB; Messer AE
    Cardiovasc Res; 2015 Oct; 108(1):99-110. PubMed ID: 26109583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.
    Lu QW; Morimoto S; Harada K; Du CK; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2003 Dec; 35(12):1421-7. PubMed ID: 14654368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.
    Mirza M; Marston S; Willott R; Ashley C; Mogensen J; McKenna W; Robinson P; Redwood C; Watkins H
    J Biol Chem; 2005 Aug; 280(31):28498-506. PubMed ID: 15923195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of a transgenic mouse model of familial dilated cardiomyopathy.
    Song W; Dyer E; Stuckey D; Leung MC; Memo M; Mansfield C; Ferenczi M; Liu K; Redwood C; Nowak K; Harding S; Clarke K; Wells D; Marston S
    J Mol Cell Cardiol; 2010 Sep; 49(3):380-9. PubMed ID: 20600154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
    Parvatiyar MS; Pinto JR
    Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
    Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
    Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis of alpha-tropomyosin linked (Asp230Asn) familial dilated cardiomyopathy.
    Lynn ML; Tal Grinspan L; Holeman TA; Jimenez J; Strom J; Tardiff JC
    J Mol Cell Cardiol; 2017 Jul; 108():127-137. PubMed ID: 28600229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy mutations increase myofilament Ca
    Robinson P; Liu X; Sparrow A; Patel S; Zhang YH; Casadei B; Watkins H; Redwood C
    J Biol Chem; 2018 Jul; 293(27):10487-10499. PubMed ID: 29760186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
    Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
    Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments.
    Mirza M; Robinson P; Kremneva E; Copeland O; Nikolaeva O; Watkins H; Levitsky D; Redwood C; El-Mezgueldi M; Marston S
    J Biol Chem; 2007 May; 282(18):13487-97. PubMed ID: 17360712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation.
    Messer AE; Bayliss CR; El-Mezgueldi M; Redwood CS; Ward DG; Leung MC; Papadaki M; Dos Remedios C; Marston SB
    Arch Biochem Biophys; 2016 Jul; 601():113-20. PubMed ID: 27036851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.
    Lombardi R; Bell A; Senthil V; Sidhu J; Noseda M; Roberts R; Marian AJ
    Cardiovasc Res; 2008 Jul; 79(1):109-17. PubMed ID: 18349139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
    Robinson P; Griffiths PJ; Watkins H; Redwood CS
    Circ Res; 2007 Dec; 101(12):1266-73. PubMed ID: 17932326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
    Bayliss CR; Jacques AM; Leung MC; Ward DG; Redwood CS; Gallon CE; Copeland O; McKenna WJ; Dos Remedios C; Marston SB; Messer AE
    Cardiovasc Res; 2013 Mar; 97(3):500-8. PubMed ID: 23097574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically Divergent Mutation Effects on the Structure and Function of the Human Cardiac Tropomyosin Overlap.
    McConnell M; Tal Grinspan L; Williams MR; Lynn ML; Schwartz BA; Fass OZ; Schwartz SD; Tardiff JC
    Biochemistry; 2017 Jul; 56(26):3403-3413. PubMed ID: 28603979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.